Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis

Osteoporosis International

Volumn 19, Issue 4, 2008, Pages 503-510

  Marquis, P ^a   Roux, C ^b   De La Loge, C ^a   Diaz Curiel, M ^c   Cormier, C ^b   Isaia, G ^d   Badurski, J ^e   Wark, J ^f   Meunier, P J ^g  

^a MAPI VALUES   (United States)

^b Hôpital Cochin ^*  (France)

^c Jimenez Diaz Foundation   (Spain)

^d UNIVERSITY OF TURIN   (Italy)

^e Centre of Osteoporosis and Osteoarticular Diseases   (Poland)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

^g UNIVERSITÉ LYON 1   (France)

Author keywords

Fractures; Osteoporosis; QUALIOST SF 36 ; Quality of life; Strontium ranelate

Indexed keywords

CALCIUM; STRONTIUM RANELATE; VITAMIN D; BONE DENSITY CONSERVATION AGENT; ORGANOMETALLIC COMPOUND; THIOPHENE DERIVATIVE;

AGED; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EMOTION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PHYSICAL CAPACITY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; VERTEBRA FRACTURE; ADULT; BONE DENSITY; DRUG EFFECT; FRACTURE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SPINE FRACTURE; TREATMENT OUTCOME;

ADULT; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; FEMALE; FRACTURES, BONE; HUMANS; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; OSTEOPOROSIS, POSTMENOPAUSAL; QUALITY OF LIFE; SPINAL FRACTURES; THIOPHENES; TREATMENT OUTCOME;

EID: 47249093704     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-007-0464-3     Document Type: Article

References (24)

1. Consensus Development Conference report (1993) Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646-650
2. Nevitt MC, Ettinger B, Black DM et al (1998) The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128:793-800 (Pubitemid 28267711)
3. Ettinger B, Black DM, Nevitt MC et al (1992) Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 7:449-456
4. The European Prospective Osteoporosis Study Group (2002) Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 17:716-724
5. Silverman SL, Minshall ME, Shen W et al (2001) The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study. Arthritis Rheum 44:2611-2619 (Pubitemid 33049339)
6. Cook DJ, Guyatt GH, Adachi JD et al (1997) Measuring quality of life in women with osteoporosis. Osteoporos Int 7:478-487 (Pubitemid 27443075)
7. Chassany O, Sagnier P, Marquis P et al (2002) Patient-reported outcomes: the example of health-related quality of life - a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inf J 36:209-238 (Pubitemid 34208219)
8. Marquis P, Cialdella P, de la Loge C (2001) Development and validation of a specific quality of life module in post-menopausal women with osteoporosis: the QUALIOST. Qual Life Res 10:555-566 (Pubitemid 34015512)
9. Ware JE, Snow KK, Kosinski MK et al (1993) SF-36 Health Survey, Manual and Interpretation Guide. The Health Institute, New England Medical Center, Boston, Massachussets
10. De la Loge C, Sullivan K, Pinkney R et al (2005) Cross-cultural validation and analysis of responsiveness of the QUALIOST®: QUAlity of Life questionnaire In OSTeoporosis. Health Qual Life Outcomes 3:69
11. Meunier PJ, Roux C, Seeman E (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459-468 (Pubitemid 38133766)
12. Reginster JY, Spector TD, Badurski J et al (2002) A short-term run-in study can significantly contribute to increasing the quality of long-term osteoporosis trials. The Strontium ranelate Phase 3 program. Osteoporos Int 13 (suppl 1): P85MO
13. Ware JE, Kosinski MK, Keller SD (1994) SF-36 Physical and Mental Health Summary Scales: A User's Manual. The Health Institute, New England Medical Center, Boston, MA
14. Cook DJ, Guyatt GH, Adachi JD et al (1993) Quality of life issues in women with vertebral fractures due to osteoporosis. Arthritis Rheum 36:750-756
15. Roberto KA (1988) Women with osteoporosis: the role of the family and service community. Gerontologist 28:224-228
16. Kotz K, Deleger S, Cohen R et al (2004) Osteoporosis and health-related quality-of-life outcomes in the Alameda County Study population. Prev Chronic Dis 1:A05.
17. Lips P, Cooper C, Agnusdei D et al (1997) Quality of life as an outcome in the treatment of Osteoporosis: The development of a questionnaire for Quality of Life by the European Foundation of Osteoporosis. 7:36-38
18. Fechtenbaum J, Cropet C, Kolta S et al (2005) The severity of vertebral fractures and health-related quality of life in osteoporotic postmenopausal women. Osteoporosis Int 16:2175-2179 (Pubitemid 41790941)
19. Jenkinson C, Stewart-Brown S, Petersen S et al (1999) Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Community Health 53:46-50 (Pubitemid 29012351)
20. Dursun N, Dursun E, Yalcin S (2001) Comparison of alendronate, calcitonin and calcium treatment in postmenopausal osteoporosis. Int J Clin Pract 55:505-509 (Pubitemid 33040548)
21. Semler J, Raue F, Grauer A et al (2002) Risedronate improves quality of life in women with osteoporosis after 6 months: results from a perspective cohort study. J Back Musculoskeletal Rehabil 17:S378
22. Oleksik AM, Ewing S, Shen W et al (2005) Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures. Osteoporos Int 16:861-870 (Pubitemid 41127094)
23. Nevitt MC, Chen P, Dore RK et al (2006). Reduced risk of back pain following teriparatide treatment: a meta-analysis. Osteoporosis Int 17:273-280 (Pubitemid 43053592)
24. European Summary of Product characteristics 2005 Available at http://www.servier.com/pro/osteoporose/protelos/protelos-spc.asp. Last accessed on 22 June 2006